PRF Technologies (PRFX) Accounts Payables (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Accounts Payables of $213000.0 for Q4 2025, down 28.04% year-on-year from $296000.0 in Q4 2024, and up 29.88% on a QoQ basis from $164000.0 in Q2 2025.

PRF Technologies (PRFX) Accounts Payables (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Accounts Payables for 7 consecutive years, with $213000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Accounts Payables fell 28.04% year-over-year to $213000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (down 28.04% YoY) and the FY2025 annual result came in at $213000.0, down 28.04% from the prior year.
  • Accounts Payables grew to $213000.0 in Q4 2025 per PRFX's latest filing, from $164000.0 in the prior quarter.
  • Over the last five years, Accounts Payables for PRFX reached as high as $385000.0 in Q3 2022 and fell as low as $57000.0 in Q2 2021.
  • A 5-year average of $195882.4 and a median of $209000.0 in 2022 frame the typical range for Accounts Payables.
  • The largest YoY upside for Accounts Payables was 338.46% in 2021 against a maximum downside of 81.11% in 2021.
  • Year by year, Accounts Payables stood at $136000.0 in 2021, then jumped by 53.68% to $209000.0 in 2022, then tumbled by 66.99% to $69000.0 in 2023, then surged by 328.99% to $296000.0 in 2024, then dropped by 28.04% to $213000.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods registered $213000.0, $164000.0, and $296000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 4.96 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.60 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 507.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 498.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 1.67 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.75 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 773.00 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 372.00 Mn
10 PRF Technologies 745,168.93 451,168.93 - 213,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 213,000.00
Jun 30, 2025 164,000.00
Dec 31, 2024 296,000.00
Jun 30, 2024 119,000.00
Mar 31, 2024 209,000.00
Dec 31, 2023 69,000.00
Sep 30, 2023 214,000.00
Jun 30, 2023 70,000.00
Mar 31, 2023 313,000.00
Dec 31, 2022 209,000.00
Sep 30, 2022 385,000.00
Jun 30, 2022 212,000.00
Mar 31, 2022 334,000.00
Dec 31, 2021 136,000.00
Sep 30, 2021 171,000.00
Jun 30, 2021 57,000.00
Mar 31, 2021 159,000.00
Dec 31, 2020 720,000.00
Jun 30, 2020 13,000.00
Dec 31, 2019 166,000.00